GlassScriptPhysician profile
Judd Harris Fastenberg
NPI 1720320492
$9,075.69
in general payments reported to CMS, 2019-2025
10 companies · $6,951 in 2025
The $6,951 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $173 · 2022: $379 · 2023: $764 · 2024: $808 · 2025: $6,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,370 · Food and Beverage: $2,402 · Travel and Lodging: $1,652 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,370.00 |
| Food and Beverage | $2,402.16 |
| Travel and Lodging | $1,651.89 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,792.55 | 2022-2025 | Fusion, Propel, Stealthstation S8 Platform |
| Stryker Corporation | $782.28 | 2021-2024 | Scopis Ent, Xpress Ent Dilation System, Nasopore |
| 3-D Matrix, INC. | $458.70 | 2024-2025 | |
| Acclarent, INC | $330.36 | 2022-2023 | Trudi Nav Cable, Relieva Spinplus |
| Sanofi-Aventis U.S. LLC | $197.98 | 2022-2025 | |
| Regeneron Pharmaceuticals, INC. | $140.01 | 2025 | Dupixent |
| Integra Lifesciences Corporation | $138.58 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Genzyme Corporation | $133.08 | 2024 | |
| Inspire Medical Systems, INC. | $58.95 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $43.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judd Fastenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.